Feeds:
Posts
Comments

Posts Tagged ‘late-stage trial’

JUNE 25: REUTERS: OncoGenex Pharmaceuticals Inc says it has reached an agreement with US health regulators to amend the design of a late-stage trial of its lead prostate cancer drug, OGX-011. READ MORE>

Read Full Post »